查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1544121

全球經皮給藥市場

Transdermal Drug Delivery
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球經皮給藥市場預計將達到2,353億美元

2023年全球經皮給藥市場預計為806億美元，預計到2030年將達2,353億美元，2023年至2030年複合年成長率為16.5%。被動交付是本報告分析的細分市場之一，預計複合年成長率為 15.1%，到分析期結束時將達到 1,235 億美元。在分析期間，主動交付領域的複合年成長率預計為 18.4%。

美國市場預計221億美元，中國預計複合年成長率15.7%

預計到 2023 年，美國經皮給藥市場將達到 221 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達356億美元，2023-2030年分析期間複合年成長率為15.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 15.1% 和 14.2%。在歐洲，德國的複合年成長率預計約為 14.6%。

全球經皮給藥市場 - 主要趨勢與促進因素總結

什麼是經皮給藥？

經經皮給藥是一種以受控方式透過皮膚給藥以達到全身作用的方法。這種藥物輸送系統對於以非侵入性、方便且有效的方式繞過胃腸道將藥物直接輸送到血液中至關重要。經皮吸收貼片是經皮給藥系統最常見的形式，用於治療多種疾病，包括慢性疼痛、荷爾蒙失衡和尼古丁成癮。經皮給藥的價值在於其能夠提高患者的依從性，降低副作用的風險，並長期維持恆定的治療藥物水平。

經皮如何改善治療效果？

經皮給藥可透過提供藥物的受控和持續釋放來改善治療效果。這種輸送方法使藥物能夠以穩定的速率被吸收，從而維持血液中的最佳治療水平。透過繞過胃腸道，經皮系統避免了胃刺激和首過代謝等問題，藥物在到達體循環之前可能會被分解。這增加了生物有效性並減少了所需劑量。此外，經皮吸收貼片使用方便，可自行給藥，提高病患對規定治療方法的遵從性。總的來說，這些好處有助於實現更有效、更可靠的治療結果。

為什麼對經皮給藥系統的需求不斷增加？

由於幾個重要因素，對經皮給藥系統的需求不斷增加。需要長期藥物管理的慢性疾病和病症的流行推動了對方便有效的藥物傳遞方法的需求。藥物配方和皮膚滲透技術的進步擴大了可經皮給藥的藥物範圍，增加了它們的適用性。對提高患者依從性和減輕頻繁給藥方案負擔的關注也推動了對經皮系統的需求。此外，經皮給藥的非侵入性使其成為希望避免注射或口服藥物的患者的一個有吸引力的選擇。新經皮技術的發展以及醫療保健行業對這些系統的日益接受正在進一步推動其採用。

經皮給藥市場成長的因素有哪些？

經皮給藥市場的成長受到多種因素的推動。慢性病和需要長期用藥的疾病的盛行率不斷增加，對有效、方便的給藥系統產生了巨大的需求。藥物配方、皮膚滲透促進劑和貼片設計的技術進步將擴大經皮給藥系統的功效和範圍，並促進其採用。此外，專注於提高患者依從性和對非侵入性藥物輸送選擇的需求也有助於市場成長。經皮系統應用的擴大，例如疼痛管理、荷爾蒙補充療法和戒菸，也進一步推動了需求。此外，有利的監管政策和新型經皮技術的開拓正在支持市場擴張。醫療保健產業對經皮給藥的接受度不斷提高，以及為提高其性能和可靠性而不斷進行的研究和開發工作，支撐了市場的成長潛力。

受訪企業範例（共12家）

  • Antares Pharma, Inc.
  • Bayer AG
  • Durect Corporation
  • Iontera, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • Novartis AG
  • Pantec Biosolutions AG
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP15288

Global Transdermal Drug Delivery Market to Reach US$235.3 Billion by 2030

The global market for Transdermal Drug Delivery estimated at US$80.6 Billion in the year 2023, is expected to reach US$235.3 Billion by 2030, growing at a CAGR of 16.5% over the analysis period 2023-2030. Passive Delivery, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$123.5 Billion by the end of the analysis period. Growth in the Active Delivery segment is estimated at 18.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$22.1 Billion While China is Forecast to Grow at 15.7% CAGR

The Transdermal Drug Delivery market in the U.S. is estimated at US$22.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$35.6 Billion by the year 2030 trailing a CAGR of 15.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.1% and 14.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.

Global Transdermal Drug Delivery Market - Key Trends & Drivers Summarized

What is Transdermal Drug Delivery and Why is it Crucial?

Transdermal Drug Delivery is a method of administering medications through the skin in a controlled manner to achieve systemic effects. This delivery system is crucial for providing a non-invasive, convenient, and effective way of delivering drugs directly into the bloodstream, bypassing the gastrointestinal tract. Transdermal patches are the most common form of transdermal drug delivery systems, used to treat various conditions such as chronic pain, hormonal imbalances, and nicotine addiction. The significance of transdermal drug delivery lies in its ability to improve patient compliance, reduce the risk of side effects, and maintain consistent therapeutic drug levels over extended periods.

How Does Transdermal Drug Delivery Improve Therapeutic Outcomes?

Transdermal Drug Delivery improves therapeutic outcomes by offering a controlled and sustained release of medication. This delivery method ensures that drugs are absorbed at a steady rate, maintaining optimal therapeutic levels in the bloodstream, which enhances efficacy and reduces the frequency of dosing. By bypassing the gastrointestinal tract, transdermal systems avoid issues such as gastric irritation and first-pass metabolism, which can degrade the drug before it reaches systemic circulation. This leads to better bioavailability and reduced dosage requirements. Additionally, transdermal patches are user-friendly and can be self-administered, improving patient adherence to prescribed treatment regimens. These benefits collectively contribute to more effective and reliable therapeutic outcomes.

Why is the Demand for Transdermal Drug Delivery Systems Increasing?

The demand for Transdermal Drug Delivery systems is increasing due to several key factors. The rising prevalence of chronic diseases and conditions that require long-term medication management drives the need for convenient and effective drug delivery methods. Advances in drug formulation and skin penetration technologies have expanded the range of drugs that can be delivered transdermally, increasing their applicability. The focus on improving patient compliance and reducing the burden of frequent dosing regimens also fuels the demand for transdermal systems. Additionally, the non-invasive nature of transdermal drug delivery makes it an attractive option for patients who prefer to avoid injections or oral medications. The development of novel transdermal technologies and the growing acceptance of these systems in the healthcare industry further support their adoption.

What Factors are Driving the Growth of the Transdermal Drug Delivery Market?

The growth in the Transdermal Drug Delivery market is driven by several factors. The increasing prevalence of chronic diseases and conditions requiring long-term medication creates a significant demand for effective and convenient drug delivery systems. Technological advancements in drug formulation, skin penetration enhancers, and patch design enhance the efficacy and range of transdermal delivery systems, driving their adoption. The focus on improving patient compliance and the need for non-invasive drug delivery options also contribute to market growth. The expanding applications of transdermal systems, including pain management, hormone replacement therapy, and smoking cessation, further boost demand. Additionally, favorable regulatory policies and the development of novel transdermal technologies support market expansion. The growing acceptance of transdermal drug delivery in the healthcare industry, coupled with ongoing research and development efforts to enhance their performance and reliability, underscores the market's potential for growth.

Select Competitors (Total 12 Featured) -

  • Antares Pharma, Inc.
  • Bayer AG
  • Durect Corporation
  • Iontera, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Nitto Denko Corporation
  • Novartis AG
  • Pantec Biosolutions AG
  • Tesa Labtec GmbH
  • Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transdermal Drug Delivery - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Preference for Non-Invasive Drug Delivery Methods
    • Advancements in Patch Technology and Formulations
    • Increasing Incidence of Chronic Diseases
    • Rising Demand for Controlled Release and Targeted Delivery
    • Expansion of Applications Beyond Pain Management
    • Market Growth in Geriatric and Pediatric Populations
    • Impact of Biotechnology and Nanotechnology Innovations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Transdermal Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Transdermal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Passive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Passive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Active by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Active by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hormone Replacement Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hormone Replacement Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hypertension by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hypertension by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Smoking Cessation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Smoking Cessation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Smoking Cessation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transdermal Drug Delivery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transdermal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transdermal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Delivery System - Passive and Active - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Transdermal Drug Delivery by Delivery System - Passive and Active Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Transdermal Drug Delivery by Delivery System - Percentage Breakdown of Value Sales for Passive and Active for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Transdermal Drug Delivery by Application - Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Transdermal Drug Delivery by Application - Percentage Breakdown of Value Sales for Analgesics, Hormone Replacement Therapy, Hypertension, Smoking Cessation and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION